best performing large cap stocks 19 december 2023 through 2 january 2024

Moderna (MRNA) had the highest return between December 19, 2023 and January 2, 2024 by a large-cap US stock, returning 30.2%.

ASSET DATE % RETURN
Moderna (MRNA)
12/19/2023 - 1/2/2024
30.19%
ANSYS (ANSS)
12/19/2023 - 1/2/2024
17.5%
MicroStrategy (MSTR)
12/19/2023 - 1/2/2024
17.42%
Rocket Lab USA (RKLB)
12/19/2023 - 1/2/2024
16.96%
TFI International (TFII)
12/19/2023 - 1/2/2024
13.09%
Viatris (VTRS)
12/19/2023 - 1/2/2024
12.77%
EXACT Sciences (EXAS)
12/19/2023 - 1/2/2024
12.66%
Dollar General (DG)
12/19/2023 - 1/2/2024
10.97%
Neurocrine Biosciences (NBIX)
12/19/2023 - 1/2/2024
9.17%
Pfizer (PFE)
12/19/2023 - 1/2/2024
8.98%
Dollar Tree (DLTR)
12/19/2023 - 1/2/2024
8.62%
Revvity (RVTY)
12/19/2023 - 1/2/2024
8.5%
CVS Health (CVS)
12/19/2023 - 1/2/2024
7.93%
Pilgrims Pride (PPC)
12/19/2023 - 1/2/2024
7.82%
Coca-Cola Consolidated (COKE)
12/19/2023 - 1/2/2024
7.62%
BioNTech SE (BNTX)
12/19/2023 - 1/2/2024
7.51%
Tyson Foods (TSN)
12/19/2023 - 1/2/2024
7.49%
Incyte (INCY)
12/19/2023 - 1/2/2024
7.35%
Kellanova (K)
12/19/2023 - 1/2/2024
7.34%
Citigroup (C)
12/19/2023 - 1/2/2024
7.33%
U-Haul (UHAL)
12/19/2023 - 1/2/2024
7.32%
James Hardie Industries PLC ADR (JHX)
12/19/2023 - 1/2/2024
7.17%
Biogen (BIIB)
12/19/2023 - 1/2/2024
6.94%
U-Haul (UHAL.B)
12/19/2023 - 1/2/2024
6.88%
Alcoa (AA)
12/19/2023 - 1/2/2024
6.8%
Large-cap stocks are treated as having a market cap of $10B+.